Table 1.
Sample | Pathway | Genes | Variants | Rare and damaging |
3905 | Glycolysis/gluconeogenesis | 89 | 32 | ALDOB p.I177L |
3923 | Purine metabolism | 21 | 9 | XDH p.R1296W |
3890 | Fatty acid beta oxidation | 17 | 4 | SLC22A5 p.V488I |
3952 | Bile acid | 79 | 33 | None |
3926 | BCAA metabolism, fatty acid, glycolysis | 60 | 22 | None |
3923 | BCAA metabolism, fatty acid, glycolysis | 60 | 21 | MAPK8IP1 p.D386E, MC4R p.I1251L |
3891 | BCAA metabolism, fatty acid | 60 | 26 | None |
3902 | BCAA metabolism, fatty acid, glycolysis | 60 | 7 | THADA p.E1741K, CLPS p.R55H |
3917 | Bile acid | 79 | 33 | TTC37 p.L1505S |
3937 | BCAA metabolism, fatty acid, glycolysis | 60 | 26 | LDLR p.P526H, FN3K p.H146R, PASK p.P1249L |
The column labeled “Pathway” represents the metabolic pathway identified by the nontargeted metabolomics. The column labeled “Genes” represents the number of genes belonging to the metabolic pathway. The column labeled “Variants” represents the number of nonsynonymous coding variants identified by the bioinformatics analysis within the genes selected for the pathway. The column labeled “Rare and damaging” represent variants with a minor allele frequency (MAF) <0.5 and considered damaging by two of three functional predication programs (SIFT, PolyPhen-2, and MutationTaster).